ISRCTN54216890已完成不适用
Substitution of calcineurin inhibitors with sirolimus on left ventricular hypertrophy (LVH) of renal transplant recipients (RTR)
San Martino University Hospital (Azienda Ospedaliera Universitaria San Martino) (Italy)0 个研究点目标入组 42 人开始时间: 2008年5月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 25-66 years, both males and females
- •2. Non diabetic RTR with biopsy-proven chronic allograft nephropathy
- •3. Patients who have received a single kidney in 2004
排除标准
- •1. Diabetic RTR
- •2. Patients receiving kidney transplant from living donors
- •3. Patients receiving dual kidney allograft
研究者
相似试验
尚未招募
不适用
Sirolimus with reduced calcineurin inhibitor regimen in ABO incompatible kidney transplantatioKCT0005271Asan Medical Center80
招募中
不适用
Efficacy of additional Calcineurin inhibitors in anti TNF-alfa antibody refractory Ulcerative colitislcerative colitisJPRN-UMIN000024936Keio University Gastroenterology and Hepatology30
已完成
4 期
Study Evaluating Sirolimus in the Treatment of Kidney TransplantKidney FailureKidney DiseasesNCT00282217Wyeth is now a wholly owned subsidiary of Pfizer100
进行中（未招募）
不适用
Immunosuppression without calcineurin inhibitors and with the use of everolimus (Certican) in HCV-infected liver transplant patients - ChT-06-02HCV cirrhosisMedDRA version: 9.1Level: LLTClassification code 10019744Term: Hepatitis CEUCTR2007-006221-27-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中（未招募）
不适用
Withdrawal of Calcineurin Inhibitors (CNIs) during administration of Mycophenolate Mofetil (MMF) in liver transplant patients suffering adverse effects from CNIs: Study of the reduction in rejection risk by therapeutic drug monitoring of Mycophenolate Mofetil - MiniCeptEUCTR2007-000789-19-BECHU de Liège, Domaine Universitaire du Sart Tilman